EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A production platform for disulfide-bonded peptides in the periplasm of Escherichia coli

Martin Gibisch, Matthias Müller, Christopher Tauer, Bernd Albrecht, Rainer Hahn, Monika Cserjan-Puschmann, Gerald Striedner

Microbial Cell Factories · 2024

DOI: 10.1186/s12934-024-02446-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Cell Factories, 2024. Verfasst von Martin Gibisch und 6 weiteren Autor:innen. Beteiligte Einrichtung: Christian Doppler Laboratory for Production of Next-Level Biopharmaceuticals in E. coli, Institute of Bioprocess Science and Engineering, Department …. Hauptthemen laut MEDLINE: Escherichia coli, Periplasm, Disulfides, Peptides. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Christian Doppler Forschungsgesellschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recombinant peptide production in Escherichia coli provides a sustainable alternative to environmentally harmful and size-limited chemical synthesis. However, in-vivo production of disulfide-bonded peptides at high yields remains challenging, due to degradation by host proteases/peptidases and the necessity of translocation into the periplasmic space for disulfide bond formation.

Results

In this study, we established an expression system for efficient and soluble production of disulfide-bonded peptides in the periplasm of E. coli . We chose model peptides with varying complexity (size, structure, number of disulfide bonds), namely parathyroid hormone 1–84, somatostatin 1–28, plectasin, and bovine pancreatic trypsin inhibitor (aprotinin). All peptides were expressed without and with the N-terminal, low molecular weight CASPON™ tag (4.1 kDa), with the expression cassette being integrated into the host genome. During BioLector™ cultivations at microliter scale, we found that most of our model peptides can only be sufficiently expressed in combination with the CASPON™ tag, otherwise expression was only weak or undetectable on SDS-PAGE. Undesired degradation by host proteases/peptidases was evident even with the CASPON™ tag. Therefore, we investigated whether degradation happened before or after translocation by expressing the peptides in combination with either a co- or post-translational signal sequence. Our results suggest that degradation predominantly happened after the translocation, as degradation fragments appeared to be identical independent of the signal sequence, and expression was not enhanced with the co-translational signal sequence. Lastly, we expressed all CASPON™-tagged peptides in two industry-relevant host strains during C-limited fed-batch cultivations in bioreactors. We found that the process performance was highly dependent on the peptide-host-combination. The titers that were reached varied between 0.6–2.6 g L −1 , and exceeded previously published data in E. coli . Moreover, all peptides were shown by mass spectrometry to be expressed to completion, including full formation of disulfide bonds.

Conclusion

In this work, we demonstrated the potential of the CASPON™ technology as a highly efficient platform for the production of soluble peptides in the periplasm of E. coli . The titers we show here are unprecedented whenever parathyroid hormone, somatostatin, plectasin or bovine pancreatic trypsin inhibitor were produced in E. coli , thus making our proposed upstream platform favorable over previously published approaches and chemical synthesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliPeriplasmDisulfidesPeptidesRecombinant ProteinsAprotinin

Stichwörter der Autor:innen

AprotininCASPON™ tagFed-batch cultivationParathyroid hormonePlectasinRecombinant peptidesSomatostatin

Substanzen

DisulfidesPeptidesRecombinant ProteinsAprotinin

Autor:innen und Institutionen

  • Christian Doppler Laboratory for Production of Next-Level Biopharmaceuticals in E. coli, Institute of Bioprocess Science and Engineering, Department of Biotechnology, University of Natural Resources and Life Sciences, V…
  • Boehringer-Ingelheim RCV GmbH & Co KG, Dr.-Boehringer-Gasse 5-11, Vienna, Austria.

Förderung

  • Christian Doppler Forschungsgesellschaft

Zitieren

APA

Gibisch, M., Müller, M., Tauer, C., Albrecht, B., Hahn, R., Cserjan-Puschmann, M., & Striedner, G. (2024). A production platform for disulfide-bonded peptides in the periplasm of Escherichia coli. Microbial Cell Factories. https://doi.org/10.1186/s12934-024-02446-6

Vancouver

Gibisch M, Müller M, Tauer C, Albrecht B, Hahn R, Cserjan-Puschmann M, et al. A production platform for disulfide-bonded peptides in the periplasm of Escherichia coli. Microbial Cell Factories. 2024. doi:10.1186/s12934-024-02446-6

BibTeX
@article{Gibisch2024,
  author = {Gibisch, Martin and Müller, Matthias and Tauer, Christopher and Albrecht, Bernd and Hahn, Rainer and Cserjan-Puschmann, Monika and Striedner, Gerald},
  title = {A production platform for disulfide-bonded peptides in the periplasm of Escherichia coli},
  journal = {Microbial Cell Factories},
  year = {2024},
  doi = {10.1186/s12934-024-02446-6}
}
Kostenlos starten →